Long‑term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: A case report

Xu,Songfeng; Yu,Xiuchun; Xu,Ming

doi:10.3892/etm.2014.2055

Long‑term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: A case report

Authors:
- Songfeng Xu
- Xiuchun Yu
- Ming Xu
View Affiliations

Affiliations: Department of Orthopedics, General Hospital of Ji'nan Military Region, Ji'nan, Shandong 250031, P.R. China
Published online on: November 7, 2014 https://doi.org/10.3892/etm.2014.2055
Pages: 117-119

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The prognosis of patients with lung cancer metastasis to the spine is poor, and the choice of surgery is questionable based on the aggressiveness of the disease. The present study describes a case of a 56‑year‑old male with metastatic spinal cord compression. The patient underwent surgery for posterior decompression and internal fixation, in addition to receiving postoperative radiation and epidermal growth factor receptor (EGFR) inhibitor medication. After 24 months, positron emission tomography‑computed tomography scan showed a reduction in the left upper lobe mass in the short axis and inactivation of the neoplasm in the left upper lobe and T9 vertebra. Based on these promising results, it is suggested that orthopedic oncologists consider the combination of radiation and EGFR inhibitor therapy with surgery for the treatment of lung cancer metastasis to the spine.

View Figures

View References

1	Sciubba DM and Gokaslan ZL: Diagnosis and management of metastatic spine disease. Surg Oncol. 15:141–151. 2006. View Article : Google Scholar : PubMed/NCBI
2	Sundaresan N, Boriani S, Rothman A and Holtzman R: Tumors of the osseous spine. J Neurooncol. 69:273–290. 2004. View Article : Google Scholar : PubMed/NCBI
3	White AP, Kwon BK, Lindskog DM, et al: Metastatic disease of the spine. J Am Acad Orthop Surg. 14:587–598. 2006.PubMed/NCBI
4	Witham TF, Khavkin YA, Gallia GL, et al: Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol. 2:87–94. 2006. View Article : Google Scholar : PubMed/NCBI
5	Black P: Spinal metastasis: current status and recommended guidelines for management. Neurosurgery. 5:726–746. 1979. View Article : Google Scholar : PubMed/NCBI
6	Stanley KE: Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 65:25–32. 1980.PubMed/NCBI
7	Freise G, Gabler A and Liebig S: Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection. Thorax. 33:228–234. 1978. View Article : Google Scholar : PubMed/NCBI
8	Sugiura H, Yamada K, Sugiura T, et al: Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res. 466:729–736. 2008. View Article : Google Scholar : PubMed/NCBI
9	Tokuhashi Y, Matsuzaki H, Oda H, et al: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 30:2186–2191. 2005. View Article : Google Scholar
10	Klimo P Jr and Schmidt MH: Surgical management of spinal metastases. Oncologist. 9:188–196. 2004. View Article : Google Scholar : PubMed/NCBI
11	Morgen SS, Lund-Andersen C, Larsen CF, et al: Prognosis in patients with symptomatic metastatic spinal cord compression: survival in different cancer diagnosis in a cohort of 2321 patients. Spine (Phila Pa 1976). 38:1362–1367. 2013. View Article : Google Scholar
12	Komatsu T, Kunieda E, et al: An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy? Neoplasma. 59:650–657. 2012. View Article : Google Scholar : PubMed/NCBI
13	Jacobs WB and Perrin RG: Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus. 11:e102001. View Article : Google Scholar
14	Agarawal JP, Swangsilpa T, van der Linden Y, et al: The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 18:747–760. 2006. View Article : Google Scholar
15	Mitsudomi T, Kosaka T, Endoh H, et al: Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol. 23:2513–2520. 2005. View Article : Google Scholar : PubMed/NCBI
16	Yokouchi H, Yamazaki K, Kinoshita I, et al: Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer. BMC Cancer. 7:512007. View Article : Google Scholar : PubMed/NCBI
17	Herbst RS, Maddox AM, Rothenberg ML, et al: Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial. J Clin Oncol. 20:3815–3825. 2002. View Article : Google Scholar : PubMed/NCBI
18	Inoue A, Saijo Y, Maemondo M, et al: Severe acute interstitial pneumonia and gefitinib. Lancet. 361:137–139. 2003. View Article : Google Scholar : PubMed/NCBI
19	Ni X, Wu P, Wu C, et al: Treatment of cervical vertebral (C1) metastasis of lung cancer with radiotherapy: A case report. Oncol Lett. 5:1129–1132. 2013.PubMed/NCBI
20	Aoude AA and Amiot LP: Surgical treatment of a patient with lung cancer metastasized to the spine with EGFR mutation: A case report. Int J Surg Case Rep. 3:510–512. 2012. View Article : Google Scholar : PubMed/NCBI